EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ADAR1 Controls Macrophage Scavenging and Lipid‐Buffering Programs in Metabolic Tissues

Achilleas Fardellas, Emelie Barreby, Madara Brice, Sebastian Nock, Jules Russick iD, Ana Vankova, Charlotte Edberg, Ida Robertsen, Jens K Hertel, Per Stål, Gunnar Mellgren, Cecilia Karlsson iD und 9 weitere

European Journal of Immunology · 2026-04 · 56 (4)

DOI: 10.1002/eji.70189 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, online erschienen am 26.04.2026. Verfasst von Achilleas Fardellas und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Gene Expression Regulation, Macrophages, Metabolic Diseases, Adenosine Deaminase. Die Arbeit nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program, Swedish Research Council, Cancerfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenosine deaminase acting on RNA 1 (ADAR1) regulates mRNA fate and function through adenosine‐to‐inosine (A‐to‐I) RNA editing and RNA‐binding activities. While its role in innate immunity is established, the broader regulatory functions of ADAR1 in macrophages remain poorly defined. Here, we systematically profiled ADAR1 expression across human immune cells and identified marked enrichment in macrophages, driven by selective usage of an alternative transcription start site during monocyte‐to‐macrophage differentiation. ADAR1 binds, edits, and modulates key macrophage targets involved in efferocytosis, endocytosis, lysosomal processing, lipid metabolism, and proliferation in an isoform‐specific manner. We further demonstrate that ADAR1 levels and activity are dynamically regulated in adipose tissue and liver during the progression of metabolic disease. Linked to this, macrophage‐specific ablation of ADAR1 co‐cultured in organotypic 3D primary human liver spheroids and exposed to metabolic stress resulted in an exacerbated lipid accumulation phenotype. Finally, we identify a lipid‐associated macrophage‐specific upregulation of ADAR1 in adipose tissue following weight loss interventions, mechanistically driven by free fatty acids. These findings uncover a previously unrecognized role for ADAR1 in lipid‐buffering, scavenging, and proliferative macrophage functions, extending its biological relevance beyond canonical interferon‐mediated immunity and establishing ADAR1 as a key regulator of macrophage adaptation in metabolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression RegulationMacrophagesMetabolic DiseasesAdenosine DeaminaseRNA-Binding ProteinsHumansAdaptation, PhysiologicalEndocytosisLipid MetabolismLysosomesPrimary Cell CultureWeight Loss

Substanzen

ADAR protein, humanAdenosine DeaminaseRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Medicine, Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Division of Surgery, Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
  • Section for Pharmacology and Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Oslo, Norway.
  • Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
  • Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Medicine, Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.

ORCID-Profile: Jules Russick, Cecilia Karlsson, Niklas K Björkström

Förderung

  • European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program
  • Swedish Research Council
  • Cancerfonden
  • Stiftelsen för Strategisk Forskning
  • Knut och Alice Wallenbergs Stiftelse
  • Center for Innovative Medicine
  • Novo nordisk fonden
  • Svenska Sällskapet för Medicinsk Forskning

Zitieren

APA

Fardellas, A., Barreby, E., Brice, M., Nock, S., Russick, J., Vankova, A., Edberg, C., Robertsen, I., Hertel, J. K., Stål, P., Mellgren, G., Karlsson, C., Hjelmesaeth, J. S., Hagström, H., Näslund, E., Lauschke, V. M., Fernø, J., Chen, P., Morgantini, C., …, & Björkström, N. K. (2026). ADAR1 Controls Macrophage Scavenging and Lipid‐Buffering Programs in Metabolic Tissues. European Journal of Immunology, 56(4). https://doi.org/10.1002/eji.70189

Vancouver

Fardellas A, Barreby E, Brice M, Nock S, Russick J, Vankova A, et al. ADAR1 Controls Macrophage Scavenging and Lipid‐Buffering Programs in Metabolic Tissues. European Journal of Immunology. 2026;56(4). doi:10.1002/eji.70189

BibTeX
@article{Fardellas2026,
  author = {Fardellas, Achilleas and Barreby, Emelie and Brice, Madara and Nock, Sebastian and Russick, Jules and Vankova, Ana and Edberg, Charlotte and Robertsen, Ida and Hertel, Jens K and Stål, Per and Mellgren, Gunnar and Karlsson, Cecilia and Hjelmesaeth, Jøran S and Hagström, Hannes and Näslund, Erik and Lauschke, Volker M and Fernø, Johan and Chen, Ping and Morgantini, Cecilia and Aouadi, Myriam and Björkström, Niklas K},
  title = {ADAR1 Controls Macrophage Scavenging and Lipid‐Buffering Programs in Metabolic Tissues},
  journal = {European Journal of Immunology},
  year = {2026},
  volume = {56},
  number = {4},
  doi = {10.1002/eji.70189}
}
Kostenlos starten →